Atlas Trials

Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease

Clinical trial NCT04330326 · COMPLETED

Trial details

NCT number
NCT04330326
Sponsor
ScandiBio Therapeutics AB
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-alcoholic Fatty Liver Disease (NAFLD)
Start date
2019-07-20
Primary completion
2020-07-29
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.